Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Arterial Hypertension
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

open access

Vol 25, No 2 (2021)
REVIEW
Published online: 2020-09-16
View PDF Download PDF file
Get Citation

Cardiovascular diseases in youth patients with glucose metabolism impairment

Aleksandra Pilśniak1, Artur Chwalba2, Ewa Otto-Buczkowska3
DOI: 10.5603/AH.a2020.0016
·
Arterial Hypertension 2021;25(2):63-68.
Affiliations
  1. Inpatient Department of Radiation and Clinical Oncology, Maria Skłodowska-Curie Institute — Oncology Center, Gliwice, Poland
  2. Department of Pharmacology, Medical University of Silesia, Zabrze, Poland
  3. Medical Specialist Centre in Gliwice, Gliwice, Poland, Gliwice, Poland

open access

Vol 25, No 2 (2021)
REVIEW
Published online: 2020-09-16

Abstract

Glucose metabolism disorders in adolescent patients have a diverse background. The most common cause is type 1 diabetes. Persistently elevated blood glucose initiates many processes that lead to blood vessel and nerve damage.

Early detection and treatment of these abnormalities can help prevent the development of many complications.

Abstract

Glucose metabolism disorders in adolescent patients have a diverse background. The most common cause is type 1 diabetes. Persistently elevated blood glucose initiates many processes that lead to blood vessel and nerve damage.

Early detection and treatment of these abnormalities can help prevent the development of many complications.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

impairments of carbohydrates metabolism; insulin resistance; hyperinsulinemia; cardiovascular disease; cardiomyopathy; macroangiopathy; blood pressure monitoring

About this article
Title

Cardiovascular diseases in youth patients with glucose metabolism impairment

Journal

Arterial Hypertension

Issue

Vol 25, No 2 (2021)

Pages

63-68

Published online

2020-09-16

Page views

756

Article views/downloads

454

DOI

10.5603/AH.a2020.0016

Bibliographic record

Arterial Hypertension 2021;25(2):63-68.

Keywords

impairments of carbohydrates metabolism
insulin resistance
hyperinsulinemia
cardiovascular disease
cardiomyopathy
macroangiopathy
blood pressure monitoring

Authors

Aleksandra Pilśniak
Artur Chwalba
Ewa Otto-Buczkowska

References (52)
  1. Sun D, Li X, Heianza Y, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003; 290(17): 2271–2276.
    CrossRefPubMed
  2. Raitakari OT, Juonala M, Kähönen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290(17): 2277–2283.
    CrossRefPubMed
  3. Babar GS, Zidan H, Widlansky ME, et al. Impaired endothelial function in preadolescent children with type 1 diabetes. Diabetes Care. 2011; 34(3): 681–685.
    CrossRefPubMed
  4. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care. 2006; 29(8): 1891–1896.
    CrossRefPubMed
  5. Graves LE, Donaghue KC. Management of diabetes complications in youth. Ther Adv Endocrinol Metab. 2019; 10: 2042018819863226.
    CrossRefPubMed
  6. Stankute I, Dobrovolskiene R, Danyte E, et al. Factors Affecting Cardiovascular Risk in Children, Adolescents, and Young Adults with Type 1 Diabetes. J Diabetes Res. 2019; 2019: 1–10.
    CrossRefPubMed
  7. Donaghue KC, Wadwa RP, Dimeglio LA, et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20: 257–269.
    CrossRefPubMed
  8. Wadwa RP. Cardiovascular disease risk in youth with diabetes mellitus. Rev Endocr Metab Disord. 2006; 7(3): 197–204.
    CrossRefPubMed
  9. Glowinska B, Urban M, Koput A. Cardiovascular risk factors in children with obesity, hypertension and diabetes: lipoprotein(a) levels and body mass index correlate with family history of cardiovascular disease. Eur J Pediatr. 2002; 161(10): 511–518.
    CrossRefPubMed
  10. Stettler C, Allemann S, Jüni P, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J. 2006; 152(1): 27–38.
    CrossRefPubMed
  11. Głowińska-Olszewska B, Luczyński W, Bossowski A. [Endothelial progenitor cells as a new marker of endothelial function with respect to risk of cardiovascular disorders]. Postepy Hig Med Dosw (Online). 2011; 65: 8–15.
    CrossRefPubMed
  12. Longo M, Scappaticcio L, Bellastella G, et al. METRO Study Group. Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study. Diabetes Metab Syndr Obes. 2020; 13: 777–784.
    CrossRefPubMed
  13. Babar G, Clements M, Dai H, et al. Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus. J Pediatr Endocrinol Metab. 2019; 32(2): 109–113.
    CrossRefPubMed
  14. Gorst C, Kwok CS, Aslam S, et al. Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis. Diabetes Care. 2015; 38(12): 2354–2369.
    CrossRefPubMed
  15. Nusca A, Tuccinardi D, Albano M, et al. Glycemic variability in the development of cardiovascular complications in diabetes. Diabetes Metab Res Rev. 2018; 34(8): e3047.
    CrossRefPubMed
  16. Xia J, Yin C. Glucose Variability and Coronary Artery Disease. Heart Lung Circ. 2019; 28(4): 553–559.
    CrossRefPubMed
  17. Costantino S, Ambrosini S, Paneni F. The epigenetic landscape in the cardiovascular complications of diabetes. J Endocrinol Invest. 2019; 42(5): 505–511.
    CrossRefPubMed
  18. Llauradó G, Gutiérrez C, Giménez-Palop O, et al. Haptoglobin genotype is associated with increased endothelial dysfunction serum markers in type 1 diabetes. Eur J Clin Invest. 2015; 45(9): 932–939.
    CrossRefPubMed
  19. Koschinsky ML, Marcovina SM. The relationship between lipoprotein(a) and the complications of diabetes mellitus. Acta Diabetol. 2003; 40(2): 65–76.
    CrossRefPubMed
  20. Siminerio LM, Albanese-O'Neill A, Chiang JL, et al. American Diabetes Association. Care of young children with diabetes in the child care setting: a position statement of the American Diabetes Association. Diabetes Care. 2014; 37(10): 2834–2842.
    CrossRefPubMed
  21. Hsueh WA, Lyon CJ, Quiñones MJ. Insulin resistance and the endothelium. Am J Med. 2004; 117(2): 109–117.
    CrossRefPubMed
  22. Lee Y, Chakraborty S, Meininger CJ, et al. Insulin resistance disrupts cell integrity, mitochondrial function, and inflammatory signaling in lymphatic endothelium. Microcirculation. 2018; 25(7): e12492.
    CrossRefPubMed
  23. Czupryniak L, Saryusz-Wolska M, Pawlowski M, et al. Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes. J Hum Hypertens. 2006; 20(3): 231–233.
    CrossRefPubMed
  24. Krishnan S, Short KR. Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes. J Cardiometab Syndr. 2009; 4(1): 50–56.
    CrossRefPubMed
  25. Mateo-Gavira I, Vílchez-López FJ, García-Palacios MV, et al. Early blood pressure alterations are associated with pro-inflammatory markers in type 1 diabetes mellitus. J Hum Hypertens. 2017; 31(2): 151–156.
    CrossRefPubMed
  26. Chessa M, Butera G, Lanza GA, et al. Role of heart rate variability in the early diagnosis of diabetic autonomic neuropathy in children. Herz. 2002; 27(8): 785–790.
    CrossRefPubMed
  27. Kowalewski MA, Urban M. Short- and long-term reproducibility of autonomic measures in supine and standing positions. Clin Sci (Lond). 2004; 106(1): 61–66.
    CrossRefPubMed
  28. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010; 33(2): 434–441.
    CrossRefPubMed
  29. Ayad F, Belhadj M, Pariés J, et al. Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications. Diabet Med. 2010; 27(7): 804–811.
    CrossRefPubMed
  30. Karavanaki K, Baum JD. Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2003; 16(1): 79–90.
    CrossRefPubMed
  31. Pietrzak I, Szadkowska A, Czerniawska E, et al. [Prehypertension risk factors in children and adolescents with type 1 diabetes]. Przegl Lek. 2006; 63 Suppl 3: 111–114.
    PubMed
  32. Pietrzak I, Mianowska B, Gadzicka A, et al. Blood pressure in children and adolescents with type 1 diabetes mellitus--the influence of body mass index and fat mass. Pediatr Endocrinol Diabetes Metab. 2009; 15(4): 240–245.
    PubMed
  33. Specht BJ, Wadwa RP, Snell-Bergeon JK, et al. Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes. J Pediatr. 2013; 162(2): 297–301.
    CrossRefPubMed
  34. Jenkins A, Januszewski A, O'Neal D. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it. Cardiovasc Endocrinol Metab. 2019; 8(1): 14–27.
    CrossRefPubMed
  35. Ferreira I, Hovind P, Schalkwijk CG, et al. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort. Diabetologia. 2018; 61(1): 231–241.
    CrossRefPubMed
  36. Machnica L, Deja G, Polanska J, et al. Blood pressure disturbances and endothelial dysfunction markers in children and adolescents with type 1 diabetes. Atherosclerosis. 2014; 237(1): 129–134.
    CrossRefPubMed
  37. Sochett E, Noone D, Grattan M, et al. Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes. Cytokine. 2017; 99: 233–239.
    CrossRefPubMed
  38. Järvisalo MJ, Lehtimäki T, Raitakari OT. Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation. 2004; 109(23): 2885–2889.
    CrossRefPubMed
  39. Tołwińska J, Głowińska-Olszewska B, Urban M, et al. [Ultrasonographic evaluation of selected parameters of the endothelial function in brachial arteries and IMT measurements in carotid arteries in children with diabetes type 1 using personal insulin pumps — preliminary report]. Pediatr Endocrinol Diabetes Metab. 2006; 12(3): 200–204.
    PubMed
  40. Lilje C, Cronan JC, Schwartzenburg EJ, et al. Intima-media thickness at different arterial segments in pediatric type 1 diabetes patients and its relationship with advanced glycation end products. Pediatr Diabetes. 2018; 19(3): 450–456.
    CrossRefPubMed
  41. Perseghin G, Lattuada G, De Cobelli F, et al. Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications. Int J Cardiol. 2012; 154(2): 111–115.
    CrossRefPubMed
  42. Snell-Bergeon JK, Budoff MJ, Hokanson JE. Vascular calcification in diabetes: mechanisms and implications. Curr Diab Rep. 2013; 13(3): 391–402.
    CrossRefPubMed
  43. de Graaf MA, Roos CJ, Mansveld JM, et al. Changes in ischaemia as assessed with single-photon emission computed tomography myocardial perfusion imaging in high-risk patients with diabetes without cardiac symptoms: relation with coronary atherosclerosis on computed tomography coronary angiography. Eur Heart J Cardiovasc Imaging. 2015; 16(8): 863–870.
    CrossRefPubMed
  44. Głowińska B, Urban M, Peczyńska J, et al. [Selected adhesion molecules: sICAM-1 and sVCAM-1 as markers of endothelial dysfunction in diabetic children and adolescence]. Pol Merkur Lekarski. 2003; 14(81): 205–209.
    PubMed
  45. Pawłowski P, Urban M, Peczyńska J. [Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?]. Pediatr Endocrinol Diabetes Metab. 2005; 11(3): 147–152.
    PubMed
  46. Schram MT, Chaturvedi N, Schalkwijk C, et al. EURODIAB Prospective Complications Study. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2003; 26(7): 2165–2173.
    CrossRefPubMed
  47. Verrotti A, Trotta D, Salladini C, et al. Preventing microvascular diabetic complications in children and adolescents: looking beyond glycaemic control. Expert Opin Pharmacother. 2003; 4(4): 525–532.
    CrossRefPubMed
  48. Demirel F, Tepe D, Kara O, et al. Microvascular complications in adolescents with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2013; 5(3): 145–149.
    CrossRefPubMed
  49. Dunger DB. Banting Memorial Lecture 2016 Reducing lifetime risk of complications in adolescents with Type 1 diabetes. Diabet Med. 2017; 34(4): 460–466.
    CrossRefPubMed
  50. Fröhlich-Reiterer EE, Huber J, Katz H, et al. [Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus]. Wien Med Wochenschr. 2010; 160(15-16): 414–418.
    CrossRefPubMed
  51. Snell-Bergeon JK, Nadeau K. Cardiovascular disease risk in young people with type 1 diabetes. J Cardiovasc Transl Res. 2012; 5(4): 446–462.
    CrossRefPubMed
  52. Bjornstad P, Donaghue KC, Maahs DM. Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment? Lancet Diabetes Endocrinol. 2018; 6(10): 809–820.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl